✦ LIBER ✦

The role of effectively treated chronic hepatitis C infection in the development of type 2 diabetes mellitus

✍ Scribed by Tugrul Purnak

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 57 KB
Volume: 49
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.22985

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New onset diabetes mellitus after liver

New onset diabetes mellitus after liver transplantation: The critical role of hepatitis C infection

✍ Mandana Khalili; Jessica Watson Lim; Nathan Bass; Nancy L. Ascher; John P. Rober 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Epidemiological studies suggest diabetes mellitus (DM) may be an extrahepatic manifestation of chronic hepatitis C virus (HCV) infection. Since diabetes and HCV are common in liver transplant recipients, we sought to examine the unique contribution of HCV infection to risk of de novo diabetes posttr

Role of non-esterified fatty acids in th

Role of non-esterified fatty acids in the pathogenesis of Type 2 diabetes mellitus

✍ Paolisso, G.; Howard, B.V. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

Over 30 years after the original description of Randle's cycle, the mechanisms by which elevated circulating non-esterified fatty acids might be causally related to glucose intolerance in Type 2 diabetes mellitus remain uncertain. This review examines the evidence that elevated plasma NEFA can inhib

Losartan reduces the onset of type 2 dia

Losartan reduces the onset of type 2 diabetes in hypertensive Japanese patients with chronic hepatitis C

✍ Yasuji Arase; Fumitaka Suzuki; Yoshiyuki Suzuki; Norio Akuta; Masahiro Kobayashi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

The aim of this retrospective cohort study is to assess the cumulative development incidence and predictive factors for type 2 diabetes (T2DM) in HCV positive and hypertensive patients treated with losartan. Eighty Japanese patients were given 50 mg of losartan per day after diagnosis of hypertensio

Infection of B cells with hepatitis C vi

Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C

✍ Momoko Inokuchi; Takayoshi Ito; Manabu Uchikoshi; Yuu Shimozuma; Kenichi Morikaw 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB 👁 1 views

## Abstract Infection with hepatitis C virus (HCV) is associated with lymphoproliferative disorders, represented by essential mixed cryoglobulinemia and B‐cell non‐Hodgkin's lymphoma, but the pathogenic mechanism remains obscure. HCV may infect B cells or interact with their cell surface receptors,

Pravastatin compared to bezafibrate in t

Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with Type 2 diabetes mellitus

✍ C. Rustemeijer; J. A. Schouten; H. J. Voerman; H. E. S. J. Hensgens; A. J. M. Do 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Background Both HMG-CoA reductase inhibitors and ®bric acid derivates are used for the treatment of dyslipidemia in Type 2 diabetes patients. The aim of this study was to compare the lipid lowering effect of 40 mg pravastatin, a HMG-CoA reductase inhibitor, and 400 mg beza®brate, a ®bric acid deriva

Molecular mechanism of insulin resistanc

Molecular mechanism of insulin resistance in type 2 diabetes mellitus: role of the insulin receptor variant forms

✍ Giorgio Sesti; Massimo Federici; Davide Lauro; Paolo Sbraccia; Renato Lauro 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB 👁 1 views